Goldman Sachs released a research report, based on the latest RMB / Hong Kong dollar exchange rate forecast, slightly lowered the target price of Ping an good Doctor (01833.HK) from 26 yuan to 25 yuan, the rating remained "neutral". The bank noted that the company's cross-selling of products to Ping an ecosystem users, as well as performance such as profit margins in pharmaceutical services and healthcare businesses, would pose potential upside or downside risks.